Literature DB >> 27030541

Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.

Julio Núñez1, Josep Comín-Colet2, Gema Miñana1, Eduardo Núñez1, Enrique Santas1, Anna Mollar1, Ernesto Valero1, Sergio García-Blas1, Ingrid Cardells1, Vicent Bodí1, Francisco J Chorro1, Juan Sanchis1.   

Abstract

AIMS: Early rehospitalization after an episode of acute heart failure (AHF) remains excessively high and its prediction a contemporary challenge. Iron deficiency (ID) is a frequent finding in AHF, but its prognostic implications remain unclear. We sought to evaluate the association between ID and risk of 30-day readmission in an unselected cohort of patients discharged for AHF. METHODS AND
RESULTS: Serum ferritin and transferrin saturation (TSAT) were measured before discharge in 626 consecutive patients with AHF in a single teaching centre. ID was defined as serum ferritin <100 µg/L (absolute ID) or ferritin 100-299 µg/L with a TSAT <20% (functional ID). Cox regression adapted for competing events was used to determine the association between ID and the risk of 30-day readmissions. Mean age was 73.4 ± 10.4 years, 48% were females, and 52.1% showed an LVEF >50%. ID was identified in 463 patients (74%): 302 (48.2%) as absolute ID and 161 (25.7%) as functional ID. At 30-day post-discharge, 20 (3.2%) patients died and 103 (16.5%) were readmitted. Patients with absolute ID showed an increased rate of readmission compared with those with functional ID and no ID (19.9, 13, and 13.5%, respectively, P = 0.005). In a multivariate setting, absolute ID remained associated with higher risk of readmission [hazard ratio (HR) 1.72; 95% confidence interval (CI) 1.13-2.60, P = 0.011]. Compared with patients without ID, functional ID was not related to the risk of readmission (HR 0.87; 95% CI 0.46-1.62, P = 0.652).
CONCLUSION: In patients with AHF, absolute ID, but not functional ID, was associated with an increased risk of early readmission.
© 2016 The Authors. European Journal of Heart Failure © 2016 European Society of Cardiology.

Entities:  

Keywords:  Acute heart failure; Iron deficiency; Rehospitalization

Mesh:

Substances:

Year:  2016        PMID: 27030541     DOI: 10.1002/ejhf.513

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  24 in total

Review 1.  Towards Holistic Heart Failure Management-How to Tackle the Iron Deficiency Epidemic?

Authors:  Lucas N L Van Aelst; Dominiek Mazure; Alain Cohen-Solal
Journal:  Curr Heart Fail Rep       Date:  2017-08

2.  Incident anaemia in older adults with heart failure: rate, aetiology, and association with outcomes.

Authors:  Andrew P Ambrosy; Jerry H Gurwitz; Grace H Tabada; Andrew Artz; Stanley Schrier; Sunil V Rao; Huiman X Barnhart; Kristi Reynolds; David H Smith; Pamela N Peterson; Sue Hee Sung; Harvey Jay Cohen; Alan S Go
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2019-10-01

3.  The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.

Authors:  Keir E J Philip; Ahmed S Sadaka; Michael I Polkey; Nicholas S Hopkinson; Andrew Steptoe; Daisy Fancourt
Journal:  Br J Haematol       Date:  2020-02-18       Impact factor: 8.615

4.  Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.

Authors:  Gema Miñana; Ingrid Cardells; Patricia Palau; Pau Llàcer; Lorenzo Fácila; Luis Almenar; Maria Pilar López-Lereu; Jose V Monmeneu; Martina Amiguet; Jessika González; Alicia Serrano; Vicente Montagud; Raquel López-Vilella; Ernesto Valero; Sergio García-Blas; Vicent Bodí; Rafael de la Espriella-Juan; Juan Sanchis; Francisco J Chorro; Antoni Bayés-Genís; Julio Núñez
Journal:  Clin Cardiol       Date:  2018-06-05       Impact factor: 2.882

Review 5.  Iron Therapy in Heart Failure: Ready for Primetime?

Authors:  Ify R Mordi; Aaron Tee; Chim C Lang
Journal:  Card Fail Rev       Date:  2018-05

Review 6.  Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.

Authors:  Marcin Drozd; Ewa A Jankowska; Waldemar Banasiak; Piotr Ponikowski
Journal:  Am J Cardiovasc Drugs       Date:  2017-06       Impact factor: 3.571

7.  Validity of the Seattle Heart Failure Model after heart failure hospitalization.

Authors:  Song Li; Patrick Marcus; Julio Núñez; Eduardo Núñez; Juan Sanchis; Wayne C Levy
Journal:  ESC Heart Fail       Date:  2019-03-01

8.  Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF).

Authors:  Tee Joo Yeo; Poh Shuan Daniel Yeo; Farid Abdul Hadi; Timothy Cushway; Kim Yee Lee; Fang Fang Yin; Anne Ching; Ruili Li; Seet Yoong Loh; Shir Lynn Lim; Raymond Ching-Chiew Wong; Bee Choo Tai; Arthur Mark Richards; Carolyn S P Lam
Journal:  ESC Heart Fail       Date:  2018-01-18

9.  Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study.

Authors:  José González-Costello; Josep Comín-Colet; Josep Lupón; Cristina Enjuanes; Marta de Antonio; Lara Fuentes; Pedro Moliner-Borja; Nuria Farré; Elisabet Zamora; Nicolás Manito; Ramón Pujol; Antoni Bayés-Genis
Journal:  BMC Cardiovasc Disord       Date:  2018-11-01       Impact factor: 2.298

Review 10.  Structural and functional abnormalities in iron-depleted heart.

Authors:  Kamil A Kobak; Malwina Radwańska; Magdalena Dzięgała; Monika Kasztura; Krystian Josiak; Waldemar Banasiak; Piotr Ponikowski; Ewa A Jankowska
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.